Navigation Links
Fluoropharma Medical To Present At Taglich Brothers 10th Annual Small Cap Equity Conference
Date:4/18/2013

New York, NY (PRWEB) April 18, 2013

Taglich Brothers, Inc. is pleased to announce that Thijs Spoor, President & CEO of FluoroPharma Medical, Inc. (OTCB: FPMI) will be presenting at their 10th Annual Small Cap Equity Conference May 7, 2013. The Conference will take place at the New York Athletic Club, New York City. To request additional information or to register, contact Taglich Brothers at 212-779-2971 or visit http://www.TaglichBrothers.com.

About Taglich Brothers:
Taglich Brothers, Inc. is a full-service broker dealer focused exclusively on microcap companies. The Company defines the microcap segment of the equity market as companies with less than $250 million in market capitalization. Taglich Brothers currently offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community.

About FluoroPharma Medical, Inc.:
FluoroPharma is a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. The Company has licensed technology from the Massachusetts General Hospital in Boston.

The Company's goal is to enable personalized medicine through precision diagnostics that will help the medical community diagnose disease more accurately at the earliest stages, leading to more effective treatment, management and better patient outcomes.

FluoroPharma's initial focus is the development of breakthrough positron emission tomography (PET) imaging agents and is advancing two products in clinical trials for assessment of acute and chronic forms of coronary disease. These first in class agents have been designed to rapidly target myocardial cells. Other products in development include agents for detection of inflamed atherosclerotic plaque in peripheral arteries, agents with the potential to image Alzheimer's disease and agents that could potentially be used for imaging specific cancers.

In addition to the United States, Europe and China, patents related to FluoroPharma's portfolio of imaging compounds have been issued in Japan, Canada, Australia, Finland, Portugal, Ireland and Mexico. For more information on the Company, please visit: http://www.fluoropharma.com

Contact:
Taglich Brothers                    
Karen Payne, Symposia Events
212-779-2971

Read the full story at http://www.prweb.com/releases/taglichbrothers/equityconference/prweb10645606.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New QuickMedical Facility Offers More Products and Enhanced Service
2. JustHomeMedical.com Launches New Bath Lifts Category
3. Magnet hospitals achieve lower mortality, reports Medical Care
4. Physician entrepreneurs are key contributors to new medical devices
5. Dr. Buckingham of Buckingham Center for Facial Plastic Surgery Re-Elected as Texas Medical Association Delegate
6. Automated Security Alert's New Medical Alarm Systems Provide A Variety Of Help
7. Christopher Jayne, M.D., Receives InTone Specialist Certification To Treat Female Urinary Incontinence From InControl Medical, LLC
8. To Stop Medical Mistakes, TOPGUN Fighter Pilot Shares Hidden Technology Secrets With Operating Room Staff At National Medical Convention
9. Travel Nursing Jobs Leader, Aureus Medical, Makes Recommendations for a Travel Nurse to Grow Professionally
10. Nuviva Medical Weight Loss Opens new Clinic in Lake Mary - Orlando
11. Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Occupational Therapy Association’s 93rd Annual Conference & Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... ... announced the official relaunch of its community and education hub for women considering ... mission is to create a safe and welcoming place for women to find ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... appointment of Jonathan (Jon) Otterstatter to its board of directors. Otterstatter ... proven leader in the development of technological innovations that lead to broad-based healthcare ...
(Date:5/24/2016)... ... May 24, 2016 , ... Bio-Logic Aqua® Research Water Life ... and a trainer for Ageless Grace ( http://www.agelessgrace.com ) to discuss healthier lifestyles, ... 16, 2016. , Formerly a Northwestern University Literature Professor, Kinst gravitated to her ...
(Date:5/24/2016)... ... May 24, 2016 , ... Controlling and maintaining the ... the launch of the Aquanta Water Heater Controller , a first-of-its-kind system that ... web-enabled device. As the Nest thermostat does for HVAC systems, Aquanta gives users ...
(Date:5/24/2016)... MA (PRWEB) , ... May 24, 2016 , ... ... Harvard Medical School, today announced a licensing relationship that will deliver a new ... This relationship will put the medical knowledge and expertise of Harvard Medical ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 2016 The innovator of ... , s first dual therapy stent, introduces catheters ... OrbusNeich, a global company specializing in the provision ... include products to treat peripheral artery disease. The JADE™ ... devices for lower limb and arteriovenous (AV) fistula intervention. ...
(Date:5/24/2016)... 2016 Les ... la première endoprothèse à double thérapie au ... portant sur les membres inférieurs et la ... entreprise mondiale spécialisée dans la fourniture de ... a élargi son portefeuille pour inclure des ...
(Date:5/24/2016)... 2016 Dutch surgeons have launched a ground-breaking ... world and treat patients on a global scale. Medical professionals from ... Asia and the US have already signed up ... networking in a totally secure environment. Education  ... working together with a surgeon at Harvard to treat a bomb ...
Breaking Medicine Technology: